Connect with us

Hi, what are you looking for?

News

BrightSphere Investment Group Inc. (BSIG) Q1 2023 Earnings Call Transcript

BrightSphere Investment Group Inc. (NYSE:BSIG) Q1 2023 Earnings Conference Call May 4, 2023 11:00 AM ET

Company Participants

Melody Huang – Senior Vice President, Director of Finance & Investor Relations

Suren Rana – President & Chief Executive Officer

Conference Call Participants

Michael Cyprys – Morgan Stanley

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the BrightSphere Investment Group Earnings Conference Call and Webcast for the First Quarter 2023. During the call, all participants will be in a listen-only mode. After the presentation, we will conduct a question-and-answer session. [Operator Instructions] Please note, this call is being recorded today, Thursday, May 4, 2023, at 11 a.m. Eastern Time.

I would now like to turn the meeting over to Melody Huang, Senior Vice President, Director of Finance and Investor Relations. Please go ahead, Melody.

Melody Huang

Good morning and welcome to BrightSphere’s conference call to discuss our results for the first quarter ended March 31, 2023. Before we get started, please note that we may make forward-looking statements about our business and financial performance. Each forward-looking statement is subject to risks and uncertainties that could cause actual results to differ materially from those projected. Additional information regarding these risks and uncertainties appears in our SEC filings, including the Form 8-K filed today containing the earnings release in our 2022 Form 10-K.

Any forward-looking statements that we make on this call are based on assumptions as of today and we undertake no obligation to update them as a result of new information or future events. We may also reference certain non-GAAP financial measures. Information about any non-GAAP measures reflected, including a reconciliation of those measures to GAAP measures can be found on our website along with the slides that we will use as part of today’s discussion. Finally, nothing herein shall be deemed to be

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Justine Koenigsberg – VP, IRNello Mainolfi –...

News

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science...

News

This article was written by Follow ONeil Trader is a former stockbroker turned full-time independent investor. He focuses on finding growth and biotech stocks...

News

Delek US Holdings, Inc. (NYSE:DK) Q3 2024 Earnings Conference Call November 6, 2024 10:00 AM ET Company Participants Robert Wright – Deputy Chief Financial...